Zhitong Finance App News, Shiyao Group (01093.HK) announced that the phase I/II clinical trial (SYS6088-001) of SYS6088 injection (this product) developed by the Group for the treatment of advanced solid tumors () has been officially launched at the first research center in China.

Zhitongcaijing · 1d ago
Zhitong Finance App News, Shiyao Group (01093.HK) announced that the phase I/II clinical trial (SYS6088-001) of SYS6088 injection (this product) developed by the Group for the treatment of advanced solid tumors () has been officially launched at the first research center in China.